W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number PXC121000J |
Device Problem
Insufficient Information (3190)
|
Patient Problems
Aneurysm (1708); Seroma (2069)
|
Event Date 07/10/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and / or require intervention include, but are not limited to aneurysm enlargement and surgical conversion.Device udi lot/serial: (b)(4), udi: (b)(4).Lot/serial: (b)(4), udi: (b)(4).Lot/serial: (b)(4), udi: (b)(4).
|
|
Event Description
|
On (b)(6) 2016, the patient underwent endovascular repair of an abdominal aortic aneurysm.A non-gore manufactured endoprosthesis (zenith device, cook medical) was deployed as a main body and gore® excluder® aaa endoprostheses contralateral leg and iliac extender components were implanted as device legs.The patient tolerated the procedure.A later follow-up study revealed aneurysm enlargement (amount of enlargement is unknown).On (b)(6) 2017, an open abdominal surgery was performed to treat the aneurysm enlargement.The existing endoprostheses were partially removed and replaced with a surgical graft.During the procedure, it was confirmed that seroma had been accumulated into the aneurysm sac (¿something that was accumulated in the aneurysm sac¿ was neither blood nor hematoma).The patient tolerated the procedure.
|
|
Search Alerts/Recalls
|
|
|